Palo Alto Investors LP
Q1 2025 13F Holdings
- Locationpalo alto, CA
- Num holdings
44
- Value ($000)
$525,145
- Date Filed05/15/2025
- Form type13F-HR
- CIK0001306923
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
INSM INSMED INC | COM PAR $.01 | 457669307 | $75.31 M | 14 % | 987,153 | ||
BMRN BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | $70.07 M | 13 % | 991,207 | ||
FOLD AMICUS THERAPEUTICS INC | COM | 03152W109 | $59.94 M | 11 % | 7,345,002 | ||
ACAD ACADIA PHARMACEUTICALS INC | COM | 004225108 | $44.25 M | 8 % | 2,663,925 | ||
UTH UNITED THERAPEUTICS CORP | COM | 91307C102 | $32.44 M | 6 % | 105,228 | ||
BIIB BIOGEN INC | COM | 09062X103 | $28.04 M | 5 % | 204,923 | ||
ALNY ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | $22.54 M | 4 % | 83,488 | ||
PTCT PTC THERAPEUTICS INC | COM | 69366J200 | $20.60 M | 4 % | 404,196 | ||
PROTHENA CORP PLC | SHS | G72800108 | $20.54 M | 4 % | 1,659,734 | ||
ANAB ANAPTYSBIO INC | COM | 032724106 | $18.98 M | 4 % | 1,020,713 |
Rows Per Page
10
- 10
- 50
- 100